12 Health Care Stocks Moving In Tuesday's Intraday Session
Portfolio Pulse from Benzinga Insights
Health care stocks experienced significant movement during Tuesday's intraday session, with Evelo Biosciences, DICE Therapeutics, Owlet, Zura Bio, Summit Therapeutics, and Biofrontera among the gainers, while Surgalign Holdings, Brainstorm Cell, Gracell Biotechnologies, XTL Biopharmaceuticals, HUTCHMED (China), and Bionomics were among the losers.
June 20, 2023 | 5:38 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Biofrontera shares moved upwards by 19.77% to $0.53, with a market cap of $14.0 million.
Biofrontera experienced a significant increase in share price during Tuesday's session, which could lead to short-term positive momentum for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
DICE Therapeutics shares increased by 37.14% to $46.42, with a market cap of $2.2 billion.
DICE Therapeutics saw a significant increase in share price during Tuesday's session, which could lead to short-term positive momentum for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Evelo Biosciences shares increased by 49.2% to $0.18 during Tuesday's regular session, with a market value of $20.0 million.
Evelo Biosciences experienced a significant increase in share price during Tuesday's session, which could lead to short-term positive momentum for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Owlet stock moved upwards by 33.2% to $0.33, with a market cap of $39.1 million.
Owlet experienced a significant increase in share price during Tuesday's session, which could lead to short-term positive momentum for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Summit Therapeutics shares moved upwards by 20.91% to $2.52, with a market value of $1.7 billion.
Summit Therapeutics experienced a significant increase in share price during Tuesday's session, which could lead to short-term positive momentum for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
Zura Bio stock moved upwards by 21.72% to $11.54, with a market value of $497.3 million.
Zura Bio experienced a significant increase in share price during Tuesday's session, which could lead to short-term positive momentum for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Brainstorm Cell shares decreased by 14.89% to $2.23, with a market cap of $87.8 million.
Brainstorm Cell experienced a significant decrease in share price during Tuesday's session, which could lead to short-term negative momentum for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Bionomics shares decreased by 12.57% to $2.4, with a market value of $19.5 million.
Bionomics experienced a significant decrease in share price during Tuesday's session, which could lead to short-term negative momentum for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Gracell Biotechnologies shares decreased by 13.24% to $4.26, with a market cap of $288.4 million.
Gracell Biotechnologies experienced a significant decrease in share price during Tuesday's session, which could lead to short-term negative momentum for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
HUTCHMED (China) shares fell 12.66% to $12.15, with a market value of $2.1 billion.
HUTCHMED (China) experienced a significant decrease in share price during Tuesday's session, which could lead to short-term negative momentum for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
Surgalign Holdings stock decreased by 77.1% to $0.28 during Tuesday's regular session, with a market cap of $2.5 million.
Surgalign Holdings experienced a significant decrease in share price during Tuesday's session, which could lead to short-term negative momentum for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
NEGATIVE IMPACT
XTL Biopharmaceuticals shares fell 13.08% to $1.13, with a market cap of $6.1 million.
XTL Biopharmaceuticals experienced a significant decrease in share price during Tuesday's session, which could lead to short-term negative momentum for the stock.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100